These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 16046439)

  • 1. Significant variation in mortality and functional outcome after acute ischaemic stroke between Western countries: data from the tinzaparin in acute ischaemic stroke trial (TAIST).
    Gray LJ; Sprigg N; Bath PM; Sørensen P; Lindenstrøm E; Boysen G; De Deyn PP; Friis P; Leys D; Marttila R; Olsson JE; O'Neill D; Ringelstein B; van der Sande JJ; Turpie AG;
    J Neurol Neurosurg Psychiatry; 2006 Mar; 77(3):327-33. PubMed ID: 16046439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of life after ischemic stroke varies in western countries: data from the tinzaparin in Acute Ischaemic Stroke Trial (TAIST).
    Sprigg N; Gray LJ; Bath PM; Christensen H; De Deyn PP; Leys D; O'Neill D; Ringelstein EB;
    J Stroke Cerebrovasc Dis; 2012 Oct; 21(7):587-93. PubMed ID: 21388828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex differences in quality of life in stroke survivors: data from the Tinzaparin in Acute Ischaemic Stroke Trial (TAIST).
    Gray LJ; Sprigg N; Bath PM; Boysen G; De Deyn PP; Leys D; O'Neill D; Ringelstein EB;
    Stroke; 2007 Nov; 38(11):2960-4. PubMed ID: 17901387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tinzaparin in acute ischaemic stroke (TAIST): a randomised aspirin-controlled trial.
    Bath PM; Lindenstrom E; Boysen G; De Deyn P; Friis P; Leys D; Marttila R; Olsson J; O'Neill D; Orgogozo J; Ringelstein B; van der Sande J; Turpie AG
    Lancet; 2001 Sep; 358(9283):702-10. PubMed ID: 11551576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stroke severity, early recovery and outcome are each related with clinical classification of stroke: data from the 'Tinzaparin in Acute Ischaemic Stroke Trial' (TAIST).
    Sprigg N; Gray LJ; Bath PM; Lindenstrøm E; Boysen G; De Deyn PP; Friis P; Leys D; Marttila R; Olsson JE; O'Neill D; Ringelstein EB; van der Sande JJ; Turpie AG;
    J Neurol Sci; 2007 Mar; 254(1-2):54-9. PubMed ID: 17258770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asymptomatic hemorrhagic transformation of infarction and its relationship with functional outcome and stroke subtype: assessment from the Tinzaparin in Acute Ischaemic Stroke Trial.
    England TJ; Bath PM; Sare GM; Geeganage C; Moulin T; O'Neill D; Woimant F; Christensen H; De Deyn P; Leys D; Ringelstein EB;
    Stroke; 2010 Dec; 41(12):2834-9. PubMed ID: 21030711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between outcome and baseline blood pressure and other haemodynamic measures in acute ischaemic stroke: data from the TAIST trial.
    Sprigg N; Gray LJ; Bath PM; Boysen G; De Deyn PP; Friis P; Leys D; Marttila R; Olsson JE; O'Neill D; Ringelstein B; van der Sande JJ; Lindenstrøm E;
    J Hypertens; 2006 Jul; 24(7):1413-7. PubMed ID: 16794492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between baseline blood pressure and computed tomography findings in acute stroke: data from the tinzaparin in acute ischaemic stroke trial (TAIST).
    Sare GM; Bath PM; Gray LJ; Moulin T; Woimant F; England T; Geeganage C; Christensen H; De Deyn PP; Leys D; O'Neill D; Ringelstein EB;
    Stroke; 2009 Jan; 40(1):41-6. PubMed ID: 18988907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enoxaparin versus tinzaparin for venous thromboembolic prophylaxis during rehabilitation after acute spinal cord injury: a retrospective cohort study comparing safety and efficacy.
    Marciniak CM; Kaplan J; Welty L; Chen D
    PM R; 2012 Jan; 4(1):11-7. PubMed ID: 22269449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health care resource use and stroke outcome. Multinational comparisons within the GAIN International trial.
    Asplund K; Ashburner S; Cargill K; Hux M; Lees K; Drummond M;
    Int J Technol Assess Health Care; 2003; 19(2):267-77. PubMed ID: 12862185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer: A Randomized Clinical Trial.
    Lee AYY; Kamphuisen PW; Meyer G; Bauersachs R; Janas MS; Jarner MF; Khorana AA;
    JAMA; 2015 Aug; 314(7):677-686. PubMed ID: 26284719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between tinzaparin and standard heparin for chronic hemodialysis in a Canadian center.
    Lord H; Jean N; Dumont M; Kassis J; Leblanc M
    Am J Nephrol; 2002; 22(1):58-66. PubMed ID: 11919404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of once daily low molecular weight heparin (tinzaparin sodium) in high risk pregnancy.
    Ní Ainle F; Wong A; Appleby N; Byrne B; Regan C; Hassan T; Milner M; Sullivan AO; White B; O'Donnell J
    Blood Coagul Fibrinolysis; 2008 Oct; 19(7):689-92. PubMed ID: 18832911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Heparin during acute ischemic stroke. Present data and clinical situation].
    Daffertshofer M; Grips E; Dempfle CE; Hennerici M
    Nervenarzt; 2003 Apr; 74(4):307-19. PubMed ID: 12707700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weight-adjusted dosing of tinzaparin in pregnancy.
    Gibson PS; Newell K; Sam DX; Mansoor A; Jiang X; Tang S; Ross S
    Thromb Res; 2013 Feb; 131(2):e71-5. PubMed ID: 23245654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early recovery and functional outcome are related with causal stroke subtype: data from the tinzaparin in acute ischemic stroke trial.
    Sprigg N; Gray LJ; Bath PM; Lindenstrøm E; Boysen G; De Deyn PP; Friis P; Leys D; Marttila R; Olsson JE; O'Neill D; Ringelstein EB; van der Sande JJ; Turpie AG;
    J Stroke Cerebrovasc Dis; 2007; 16(4):180-4. PubMed ID: 17689415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tinzaparin use in pregnancy: an international, retrospective study of the safety and efficacy profile.
    Nelson-Piercy C; Powrie R; Borg JY; Rodger M; Talbot DJ; Stinson J; Greer IA
    Eur J Obstet Gynecol Reprod Biol; 2011 Dec; 159(2):293-9. PubMed ID: 21945573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elderly patients treated with tinzaparin (Innohep) administered once daily (175 anti-Xa IU/kg): anti-Xa and anti-IIa activities over 10 days.
    Siguret V; Pautas E; Février M; Wipff C; Durand-Gasselin B; Laurent M; Andreux JP; d'Urso M; Gaussem P
    Thromb Haemost; 2000 Nov; 84(5):800-4. PubMed ID: 11127859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting outcome in hyper-acute stroke: validation of a prognostic model in the Third International Stroke Trial (IST3).
    ; ; Lewis SC; Sandercock PA; Dennis MS
    J Neurol Neurosurg Psychiatry; 2008 Apr; 79(4):397-400. PubMed ID: 17766429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.